vs
Side-by-side financial comparison of Clearfield, Inc. (CLFD) and GYRE THERAPEUTICS, INC. (GYRE). Click either name above to swap in a different company.
GYRE THERAPEUTICS, INC. is the larger business by last-quarter revenue ($37.2M vs $34.3M, roughly 1.1× Clearfield, Inc.). Clearfield, Inc. runs the higher net margin — -1.8% vs -3.7%, a 1.9% gap on every dollar of revenue. On growth, GYRE THERAPEUTICS, INC. posted the faster year-over-year revenue change (33.4% vs -3.2%). Clearfield, Inc. produced more free cash flow last quarter ($-2.4M vs $-5.8M). Over the past eight quarters, GYRE THERAPEUTICS, INC.'s revenue compounded faster (17.0% CAGR vs -3.5%).
Clearfield, Inc. is a company headquartered in Minneapolis, Minnesota. The company produces fiber optic products.
GYRE Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to developing novel targeted therapies for hard-to-treat hematologic malignancies and solid tumors. It focuses on precision oncology to address unmet patient needs, with operations primarily based in North America.
CLFD vs GYRE — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $34.3M | $37.2M |
| Net Profit | $-614.0K | $-1.4M |
| Gross Margin | 33.2% | 95.3% |
| Operating Margin | -5.3% | 0.3% |
| Net Margin | -1.8% | -3.7% |
| Revenue YoY | -3.2% | 33.4% |
| Net Profit YoY | 67.8% | -340.1% |
| EPS (diluted) | $-0.04 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $34.3M | $37.2M | ||
| Q3 25 | $23.4M | $30.6M | ||
| Q2 25 | $49.9M | $26.8M | ||
| Q1 25 | $47.2M | $22.1M | ||
| Q4 24 | $29.7M | $27.9M | ||
| Q3 24 | $5.6M | $25.5M | ||
| Q2 24 | $48.8M | $25.2M | ||
| Q1 24 | $36.9M | $27.2M |
| Q4 25 | $-614.0K | $-1.4M | ||
| Q3 25 | $-9.1M | $5.9M | ||
| Q2 25 | $1.6M | $1.6M | ||
| Q1 25 | $1.3M | $3.7M | ||
| Q4 24 | $-1.9M | $569.0K | ||
| Q3 24 | — | $2.9M | ||
| Q2 24 | $-447.0K | $4.5M | ||
| Q1 24 | $-5.9M | $9.9M |
| Q4 25 | 33.2% | 95.3% | ||
| Q3 25 | 53.2% | 94.7% | ||
| Q2 25 | 30.5% | 95.7% | ||
| Q1 25 | 30.1% | 95.9% | ||
| Q4 24 | 29.2% | 95.8% | ||
| Q3 24 | — | 96.2% | ||
| Q2 24 | 21.9% | 96.9% | ||
| Q1 24 | 7.7% | 96.4% |
| Q4 25 | -5.3% | 0.3% | ||
| Q3 25 | 10.3% | 22.7% | ||
| Q2 25 | 3.0% | 8.1% | ||
| Q1 25 | 0.6% | 10.3% | ||
| Q4 24 | -6.9% | 2.4% | ||
| Q3 24 | — | 16.6% | ||
| Q2 24 | -4.7% | 12.7% | ||
| Q1 24 | -26.4% | 29.7% |
| Q4 25 | -1.8% | -3.7% | ||
| Q3 25 | -38.8% | 19.4% | ||
| Q2 25 | 3.2% | 5.9% | ||
| Q1 25 | 2.8% | 16.9% | ||
| Q4 24 | -6.4% | 2.0% | ||
| Q3 24 | — | 11.2% | ||
| Q2 24 | -0.9% | 18.0% | ||
| Q1 24 | -16.0% | 36.6% |
| Q4 25 | $-0.04 | $-0.01 | ||
| Q3 25 | $-0.65 | $0.03 | ||
| Q2 25 | $0.11 | $0.00 | ||
| Q1 25 | $0.09 | $0.00 | ||
| Q4 24 | $-0.13 | $0.00 | ||
| Q3 24 | — | $0.01 | ||
| Q2 24 | $-0.04 | $0.01 | ||
| Q1 24 | $-0.40 | $0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $96.4M | $52.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $249.7M | $106.0M |
| Total Assets | $268.1M | $166.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $96.4M | $52.4M | ||
| Q3 25 | $106.0M | $60.0M | ||
| Q2 25 | $117.2M | $54.4M | ||
| Q1 25 | $112.0M | $29.9M | ||
| Q4 24 | $113.0M | $26.7M | ||
| Q3 24 | $129.0M | $25.1M | ||
| Q2 24 | $123.8M | $25.1M | ||
| Q1 24 | $142.9M | $37.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $2.2M | — | ||
| Q2 24 | $2.1M | — | ||
| Q1 24 | — | — |
| Q4 25 | $249.7M | $106.0M | ||
| Q3 25 | $256.2M | $101.9M | ||
| Q2 25 | $264.5M | $92.0M | ||
| Q1 25 | $265.9M | $68.1M | ||
| Q4 24 | $267.4M | $63.3M | ||
| Q3 24 | $275.8M | $63.2M | ||
| Q2 24 | $274.6M | $60.4M | ||
| Q1 24 | $279.2M | $56.6M |
| Q4 25 | $268.1M | $166.1M | ||
| Q3 25 | $306.2M | $159.4M | ||
| Q2 25 | $314.7M | $152.6M | ||
| Q1 25 | $310.9M | $129.8M | ||
| Q4 24 | $303.2M | $125.4M | ||
| Q3 24 | $315.3M | $125.2M | ||
| Q2 24 | $318.1M | $120.9M | ||
| Q1 24 | $315.4M | $122.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.01× | — | ||
| Q2 24 | 0.01× | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.4M | $-5.6M |
| Free Cash FlowOCF − Capex | $-2.4M | $-5.8M |
| FCF MarginFCF / Revenue | -7.1% | -15.5% |
| Capex IntensityCapex / Revenue | 2.9% | 0.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-180.0K |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-1.4M | $-5.6M | ||
| Q3 25 | — | $4.7M | ||
| Q2 25 | $7.9M | $2.1M | ||
| Q1 25 | $3.0M | $-129.0K | ||
| Q4 24 | $7.2M | $-2.8M | ||
| Q3 24 | $22.2M | $1.7M | ||
| Q2 24 | $4.0M | $-5.5M | ||
| Q1 24 | $-5.7M | $2.9M |
| Q4 25 | $-2.4M | $-5.8M | ||
| Q3 25 | — | $4.0M | ||
| Q2 25 | $7.5M | $1.8M | ||
| Q1 25 | $654.0K | $-251.0K | ||
| Q4 24 | $5.1M | $-2.8M | ||
| Q3 24 | $18.2M | $1.0M | ||
| Q2 24 | $2.8M | $-6.9M | ||
| Q1 24 | $-7.7M | $2.7M |
| Q4 25 | -7.1% | -15.5% | ||
| Q3 25 | — | 13.1% | ||
| Q2 25 | 15.1% | 6.8% | ||
| Q1 25 | 1.4% | -1.1% | ||
| Q4 24 | 17.1% | -10.1% | ||
| Q3 24 | 323.0% | 4.1% | ||
| Q2 24 | 5.8% | -27.5% | ||
| Q1 24 | -20.8% | 9.8% |
| Q4 25 | 2.9% | 0.4% | ||
| Q3 25 | 2.0% | 2.2% | ||
| Q2 25 | 0.8% | 1.0% | ||
| Q1 25 | 5.1% | 0.6% | ||
| Q4 24 | 7.0% | 0.2% | ||
| Q3 24 | 71.4% | 2.7% | ||
| Q2 24 | 2.5% | 5.8% | ||
| Q1 24 | 5.3% | 0.9% |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.79× | ||
| Q2 25 | 4.93× | 1.32× | ||
| Q1 25 | 2.30× | -0.03× | ||
| Q4 24 | — | -4.85× | ||
| Q3 24 | — | 0.60× | ||
| Q2 24 | — | -1.21× | ||
| Q1 24 | — | 0.29× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
